{"id":23154,"date":"2026-10-22T14:08:54","date_gmt":"2026-10-22T11:08:54","guid":{"rendered":"https:\/\/farmacija-mic.lv\/?p=23154"},"modified":"2026-10-22T14:20:01","modified_gmt":"2026-10-22T11:20:01","slug":"hepatoprotektori-aknu-slimibu-parvaldiba-aktualais","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/","title":{"rendered":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Kaspars Ivanovs,<\/strong> \u0101rsts<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Jekaterina Parovin\u010daka<\/strong>, Dr.pharm.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p class=\"wp-block-paragraph\">Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101.<\/p>\n<\/blockquote>\n\n\n\n<p class=\"wp-block-paragraph\">Pasaul\u0113 pacientu skaits ar aknu slim\u012bb\u0101m (taukain\u0101 hepatoze, aknu ciroze, hepat\u012bts u.c.) pieaug ik gadu. Aknas ietekm\u0113jo\u0161ie kait\u012bgie faktori ir stress, trekna p\u0101rtika, p\u0101rm\u0113r\u012bgs alkohola pat\u0113ri\u0146\u0161, p\u0101rtik\u0101 eso\u0161ie kancerog\u0113ni, nikot\u012bns un citi toks\u012bni. Aknu slim\u012bbas izraisa noz\u012bm\u012bgas cie\u0161anas pacientam un rada izmaksas vesel\u012bbas sist\u0113m\u0101m vis\u0101 pasaul\u0113.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aknu funkcion\u0101lie testi pal\u012bdz diagnostic\u0113t aknu slim\u012bbas. Aknu audu boj\u0101juma gad\u012bjum\u0101 paaugstin\u0101s alan\u012bna aminotransfer\u0101zes (AlAT), aspart\u0101ta aminotransfer\u0101zes (AsAT), GGT un citu fermentu un bilirub\u012bna l\u012bmenis serum\u0101. AlAT ir ferments, ko uzskata par specifisku aknu slim\u012bbas r\u0101d\u012bt\u0101ju.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neskatoties uz milz\u012bgiem m\u016bsdienu medic\u012bnas sasniegumiem, nav izstr\u0101d\u0101ts piln\u012bgi efekt\u012bvs medikaments, kas stimul\u0113tu aknu darb\u012bbu, nodro\u0161in\u0101tu piln\u012bgu org\u0101na aizsardz\u012bbu vai pal\u012bdz\u0113tu atjaunot aknu \u0161\u016bnas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Da\u017eu augu izmanto\u0161anai ir b\u016btiska noz\u012bme aknu slim\u012bbu \u0101rst\u0113\u0161an\u0101 \u2013 apm\u0113ram 80% pasaules iedz\u012bvot\u0101ju ir izmantoju\u0161i tradicion\u0101lo medic\u012bnu, kuras pamat\u0101 galvenok\u0101rt ir dabisk\u0101s izejvielas. Literat\u016br\u0101 aprakt\u012bta da\u017e\u0101du fito\u0137\u012bmisko vielu ietekme uz aknu vesel\u012bbu. Papildu \u0161iem p\u0113t\u012bjumiem sena v\u0113sture ir emp\u012briskiem pier\u0101d\u012bjumiem par dabisku l\u012bdzek\u013cu izmanto\u0161anu aknu slim\u012bbu \u0101rst\u0113\u0161an\u0101.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hepatoprotektori ir \u0137\u012bmiskas vielas, kas sp\u0113j nov\u0113rst aknu boj\u0101jumus. To darb\u012bba ir pret\u0113ja hepatotoksiskumam. Hepatoprotektorus efekt\u012bvi lieto da\u017e\u0101du aknu boj\u0101jumu \u2013 visbie\u017e\u0101k hroniska alkoholisma, aknu iekaisuma vai hepatotoksisku vielu p\u0101rdoz\u0113\u0161anas \u2013 gad\u012bjum\u0101. Hepatoprotektori ir efekt\u012bvi ar\u012b pacientiem ar paaugstin\u0101tu aminotransfer\u0101\u017eu l\u012bmeni un cit\u0101m aknu funkcion\u0101lo testu izmai\u0146\u0101m, kam nav zin\u0101ms c\u0113lonis (1, 2).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Hepatoprotektori, ko izmanto medic\u012bn\u0101<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hol\u012bns<\/strong> ir uzturviela (esenci\u0101lie fosfolip\u012bdi), kas nepiecie\u0161ama vair\u0101ku vielmai\u0146as procesu nodro\u0161in\u0101\u0161an\u0101 organism\u0101. Hol\u012bns ar\u012b nepiecie\u0161ams, lai sintez\u0113tu fosfatidilhol\u012bnu un sfingomiel\u012bnu \u2013 divus galvenos fosfolip\u012bdus, kas ir b\u016btiskas visu augu un dz\u012bvnieku \u0161\u016bnu membr\u0101nu sast\u0101vda\u013cas. Turkl\u0101t hol\u012bns ir nepiecie\u0161ams, lai sintez\u0113tu neirotransmiteru acetilhol\u012bnu, kas nodro\u0161ina vair\u0101kas smadze\u0146u un nervu sist\u0113mas funkcijas, ietekm\u0113 atmi\u0146u, garast\u0101vokli, musku\u013cu kontroli.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hol\u012bns tiek sintez\u0113ts endog\u0113niski akn\u0101s, bet sint\u0113ze nenodro\u0161ina pietiekamu daudzumu visiem procesiem, kur tas nepiecie\u0161ams (3). Hol\u012bns papildus ir j\u0101uz\u0146em ar uzturu (4). Galvenie hol\u012bna avoti ir dz\u012bvnieku izcelsmes produkti \u2013 liellopu aknas, olas, ga\u013ca, m\u0101jputni, zivis, piena produkti. Iev\u0113rojams hol\u012bna daudzums ir krustzie\u017eu dzimtas d\u0101rze\u0146os, atsevi\u0161\u0137\u0101s pup\u0101s, to satur ar\u012b rieksti, s\u0113klas un veseli graudi (5).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Organismam nepiecie\u0161amais hol\u012bna daudzums var at\u0161\u0137irties atkar\u012bb\u0101 no \u0123en\u0113tisk\u0101s predispoz\u012bcijas un hormoniem. Vid\u0113ji tas ir 450 mg dien\u0101. V\u012brie\u0161iem un b\u0113rnu ar kr\u016bti barojo\u0161\u0101m m\u0101t\u0113m uztur\u0101 vajag vair\u0101k hol\u012bna \u2013 550 mg dien\u0101 (6, 7). Statistikas dati liecina, ka \u0161\u0101du hol\u012bna daudzumu no uztura m\u0113s uz\u0146emam reti. Visbie\u017e\u0101k iev\u0113rot\u0101 di\u0113ta ir ar zemu hol\u012bna saturu. Piem\u0113ram, ASV dati liecina, ka tikai 11% pieaugu\u0161o amerik\u0101\u0146u sasniedz hol\u012bna dienas normu (8). Ja tr\u016bkst pietiekami daudz hol\u012bna, rodas aknu boj\u0101jumi (9).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Esenci\u0101lie fosfolip\u012bdi tiek efekt\u012bvi izmantoti aknu slim\u012bbu atbalsta terapija, pazeminot AlAT, triglicer\u012bdu un holester\u012bna l\u012bmeni un uzlabojot slim\u012bbas prognozi (10). Esenci\u0101liem fosfolip\u012bdiem piem\u012bt sp\u0113ja saist\u012bties ar boj\u0101to membr\u0101nu da\u013c\u0101m, kas uzlabo aknu re\u0123ener\u0101ciju, palielina \u0161\u016bnu membr\u0101nu pl\u016bstam\u012bbu un funkcion\u0113\u0161anu. Esenci\u0101liem fosfolip\u012bdiem piem\u012bt antioksidantu, pretiekaisuma, antifibrotiska, re\u0123enerat\u012bva, membr\u0101nu atjaunojo\u0161a un aizsarg\u0101jo\u0161a darb\u012bba, k\u0101 ar\u012b ietekme uz lip\u012bdu regul\u0101ciju (11).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aknu slim\u012bbu \u0101rst\u0113\u0161an\u0101 augu izcelsmes prepar\u0101tiem ir sena lieto\u0161anas prakse. Viens no tiem ir <strong>silimar\u012bns, kam gadsimtiem ilgi bijusi \u013coti liela noz\u012bme aknu slim\u012bbu, \u012bpa\u0161i hronisku aknu slim\u012bbu, cirozes un hepatocelul\u0101r\u0101s karcinomas terapij\u0101. Silimar\u012bns<\/strong> ir \u012bst\u0101 m\u0101rdad\u017ea (<em>Silybum marianum<\/em>) ekstrakts. To pirmo reizi 1968. gad\u0101 patent\u0113ja Minhenes universit\u0101tes zin\u0101tnieki k\u0101 specifisku l\u012bdzekli \u201cpret aknu slim\u012bb\u0101m\u201d. Silimar\u012bnampiem\u012bt antioksidanta, pretiekaisuma un antifibrotiska iedarb\u012bba. T\u0101 ir \u201cfunkcion\u0101l\u0101 tri\u0101de\u201d, kas \u013cauj nov\u0113rst aknu boj\u0101jumu ra\u0161anos un progres\u0113\u0161anu, piem\u0113ram, hepat\u012bta progres\u0113\u0161anu l\u012bdz cirozei un hepatocelul\u0101rai karcinomai. K\u0101 pier\u0101d\u012bts <em>in vitro<\/em> un <em>in vivo<\/em> p\u0113t\u012bjumos, silimar\u012bna antioksidanta aktivit\u0101te nodro\u0161ina gan t\u0101 sp\u0113ju saist\u012bt br\u012bvos radik\u0101\u013cus, gan inhib\u0113t lip\u012bdu peroksid\u0101ciju (12). Samazinot oksidat\u012bvo stresu un ar to saist\u012bto citotoksiskumu, silimar\u012bns aizsarg\u0101 veselas aknu \u0161\u016bnas un t\u0101s \u0161\u016bnas, kas v\u0113l nav neatgriezeniski boj\u0101tas, nodro\u0161inot hepatoprotekt\u012bvu efektu.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Turkl\u0101t pacientiem ar hiperholesterin\u0113miju silimar\u012bns sp\u0113j samazin\u0101t holester\u012bna sint\u0113zi, inhib\u0113jot HMG-CoA redukt\u0101zi, l\u012bdz\u012bgi stat\u012bniem. Silimar\u012bns ar\u012b uzlabo glik\u0113mijas kontroli pacientiem ar cukura diab\u0113tu. Silimar\u012bns ir taukos \u0161\u0137\u012bsto\u0161s, tam piem\u012bt zems blakuspar\u0101d\u012bbu risks. Pacientiem ar aknu slim\u012bb\u0101m silimar\u012bna lieto\u0161ana j\u0101s\u0101k p\u0113c iesp\u0113jas agr\u0101k, kad aknu \u0123ener\u0101cijas potenci\u0101ls joproj\u0101m ir augsts (13).&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u0100rstniec\u012bbas pienenes(<em>Taraxacum officinale<\/em>)&nbsp;saknes ekstraktubie\u017ei izmanto da\u017e\u0101du aknu slim\u012bbu \u0101rst\u0113\u0161anai un profilaksei, jo t\u0101 sast\u0101vs ir bag\u0101ts ar fito\u0137\u012bmisk\u0101m viel\u0101m ar pier\u0101d\u012btu efektivit\u0101ti pret aknu boj\u0101jumiem. Augu no seniem laikiem izmanto tautas medic\u012bn\u0101. \u0160odienas zin\u0101tnisk\u0101 literat\u016br\u0101 aprakst\u012btas t\u0101 antioksidanta, hepatoprotekt\u012bvas \u012bpa\u0161\u012bbas, darb\u012bba pret v\u0113zi, aptauko\u0161anos, diab\u0113tu, v\u012brusiem, kol\u012btu. Galvenais pienenes saknes hepatoprotekt\u012bv\u0101s darb\u012bbas meh\u0101nisms ir oksidat\u012bv\u0101 stresa mazin\u0101\u0161ana (14, 15).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cits b\u016btisks dabisks l\u012bdzeklis aknu vesel\u012bbai ir <strong>arti\u0161oks<\/strong> <em>(Cynara scolymus)<\/em> \u2013 tas ir bag\u0101ts ar antioksidantiem, bie\u017ei tiek audz\u0113ts Vidusj\u016bras valst\u012bs. <em>In vitro<\/em> un <em>in vivo<\/em> p\u0113t\u012bjumos arti\u0161oka ekstraktam pier\u0101d\u012bta hepatoprotekt\u012bva, holer\u0113tiska, hipoholesterin\u0113miska, pretmikrobu, hipoglik\u0113miska un pretv\u0113\u017ea darb\u012bba. Arti\u0161oka papildu lieto\u0161ana b\u016btiski ietekm\u0113 seruma AlAT un AsAT l\u012bmeni&nbsp;(16). Kl\u012bniskos p\u0113t\u012bjumos pier\u0101d\u012bts, ka arti\u0161oka lieto\u0161ana iev\u0113rojami pazemin\u0101ja aknu enz\u012bmu l\u012bmeni, \u012bpa\u0161i pacientiem ar bezalkoholisko taukaino aknu slim\u012bbu (17).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aknu slim\u012bbu profilaksei un aknu darb\u012bbas uzraudz\u012bbai ir liela noz\u012bme.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Profilakse ietver \u0161\u0101dus pas\u0101kumus:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ierobe\u017eot alkohola lieto\u0161anu;<\/li>\n\n\n\n<li>vakcin\u0113ties pret v\u012brushepat\u012btu, \u012bpa\u0161i ja ir paaugstin\u0101ts infekcijas risks;<\/li>\n\n\n\n<li>lietot uzturu, kas bag\u0101ts ar akn\u0101m labv\u0113l\u012bg\u0101m uzturviel\u0101m (fosfolip\u012bdiem);<\/li>\n\n\n\n<li>uztur\u0113t vesel\u012bgu \u0137erme\u0146a masu. Aptauko\u0161an\u0101s var izrais\u012bt bezalkoholisko taukaino aknu slim\u012bbu, kas\u00a0 veicina taukaino hepatozi un cirozi;<\/li>\n\n\n\n<li>visp\u0101r\u0113ja vesel\u012bbas str\u0101vok\u013ca un aknu funkcion\u0101lo testu v\u0113rt\u0113\u0161ana.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Nov\u0113rojuma rezult\u0101ti<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u0160ogad tika veikts nov\u0113rojums, kura m\u0113r\u0137is bija noskaidrot, k\u0101 uzlabojas aknu r\u0101d\u012bt\u0101ji&nbsp;\u2013 kop\u0113j\u0101 bilirub\u012bna l\u012bmenis (\u00b5mol\/l), tie\u0161\u0101 bilirub\u012bna l\u012bmenis (\u00b5mol\/l), AlAT l\u012bmenis (vien\u012bbas litr\u0101, v\/l), AsAT l\u012bmenis (v\/l), lietojot Latvijas farm\u0101cijas uz\u0146\u0113muma <em>Lotos Pharma<\/em> ra\u017eoto prepar\u0101tu <em>Hepasan\u00ae Forte<\/em>. Prepar\u0101ta 2 kapsulu sast\u0101v\u0101 ir \u0161\u0101das akt\u012bv\u0101s vielas: hol\u012bna bitartr\u0101ts 200 mg, m\u0101rdad\u017ea (<em>Silybum marianum<\/em>) s\u0113klu sausais ekstrakts (silimar\u012bns 80%) 100 mg, pienenes&nbsp; (<em>Taraxacum officinale<\/em>) saknes sausais ekstrakts 4:1 \u2013 100 mg, arti\u0161oka (<em>Cynara scolymus<\/em>) lapu sausais ekstrakts 4:1 \u2013 100 mg.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asto\u0146u ned\u0113\u013cu ilgu nov\u0113rojumu s\u0101ka 90 pacienti, no kuriem divi p\u0113t\u012bjumu nepabeidza. Nov\u0113rojums norisin\u0101j\u0101s devi\u0146u \u0123imenes \u0101rstu uzraudz\u012bb\u0101, kuru priv\u0101tprakses atrodas R\u012bg\u0101, Daugavpil\u012b un R\u0113zekn\u0113. Pacienti tika izv\u0113l\u0113ti nejau\u0161\u0101 izlas\u0113, ja vi\u0146iem anal\u012bz\u0113s bija paaugstin\u0101ts k\u0101ds no nov\u0113rojuma m\u0113r\u0137\u012b izvirz\u012btajiem aknu r\u0101d\u012bt\u0101jiem. Nov\u0113rojuma dal\u012bbnieki lietoja divas <em>Hepasan\u00ae Forte<\/em> kapsulas dien\u0101, kas ir noteikt\u0101 diennakts deva.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Respondentu vecums bija no 18 l\u012bdz 84 gadiem. Visliel\u0101kais dal\u012bbnieku skaits bija vecumgrup\u0101 no 50 l\u012bdz 69 gadiem (49%). No visiem respondentiem 57% bija sievietes un 43% v\u012brie\u0161i. AlAT\/AsAT r\u0101d\u012bt\u0101ji gan sieviet\u0113m, gan v\u012brie\u0161iem bija nedaudz paaugsti\u00adn\u0101ti*.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sal\u012bdzinot ieg\u016bto asins anal\u012b\u017eu rezult\u0101tus pirms un p\u0113c asto\u0146u ned\u0113\u013cu <em>Hepasan\u00ae Forte<\/em> lieto\u0161anas, konstat\u0113tas statistiski b\u016btiskas at\u0161\u0137ir\u012bbas AsAT\/AlAT r\u0101d\u012bt\u0101jos. Vid\u0113jais AsAT l\u012bmenis pirms prepar\u0101ta&nbsp; lieto\u0161anas bija 52,09 v\/l, bet p\u0113c t\u0101 lieto\u0161anas 34,86 v\/l, l\u012bmenis pazemin\u0101j\u0101s par 17,23 v\/l jeb 33,07% (p&lt;0,00001). Vid\u0113jais AlAT l\u012bmenis pirms prepar\u0101ta lieto\u0161anas bija 69,60 v\/l, p\u0113c lieto\u0161anas 42,00 v\/l, l\u012bmenis pazemin\u0101j\u0101s par 27,60 v\/l jeb 39,66% (p&lt;0,00001) (sk. 1.att.).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"722\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/1stt_hepa-1024x722.jpg\" alt=\"\" class=\"wp-image-23155\" srcset=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/1stt_hepa-1024x722.jpg 1024w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/1stt_hepa-300x212.jpg 300w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/1stt_hepa-1400x987.jpg 1400w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/1stt_hepa.jpg 1476w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">1.att\u0113ls. Hepasan\u00ae Forte nov\u0113rojuma AsAT\/AlAT r\u0101d\u012bt\u0101ju izmai\u0146as asto\u0146u ned\u0113\u013cu period\u0101, v\/l<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Starp AsAT\/AlAT s\u0101kotn\u0113jo l\u012bmeni un v\u0113rt\u012bb\u0101m p\u0113c asto\u0146\u0101m ned\u0113\u013c\u0101m past\u0101v vid\u0113ji sp\u0113c\u012bga korel\u0101cija, kas nor\u0101da uz v\u0101ju, bet pozit\u012bvu tendenci, ka augst\u0101ku s\u0101kotn\u0113jo v\u0113rt\u012bbu gad\u012bjum\u0101, ir augst\u0101kas v\u0113rt\u012bbas p\u0113c asto\u0146\u0101m ned\u0113\u013c\u0101m (attiec\u012bgi r=0,5567 un r=0,6892). Interesanti, ka, v\u0113rt\u0113jot&nbsp; saist\u012bbu starp respondentu vecumu un AsAT\/AlAT l\u012bmeni pirms nov\u0113rojuma, korel\u0101cijas koeficients bija tuvs nullei vai negat\u012bvs, kas liecina, ka nepast\u0101v saist\u012bba starp respondentu vecumu un r\u0101d\u012bt\u0101ju s\u0101kotn\u0113jo l\u012bmeni.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vid\u0113jais AsAT starp vecumgrup\u0101m pirms <em>Hepasan\u00ae Forte<\/em> lieto\u0161anas bija 53,49 v\/l (SN\u00b16,80) un p\u0113c asto\u0146\u0101m ned\u0113\u013c\u0101m bija 35,72 v\/l (SN\u00b13,11), kas liecina par r\u0101d\u012bt\u0101ju samazin\u0101\u0161anos par 17,78 v\/l (SN\u00b15,00) (sk. 2.att.).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"713\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/2stt_hepa-1024x713.jpg\" alt=\"\" class=\"wp-image-23158\" srcset=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/2stt_hepa-1024x713.jpg 1024w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/2stt_hepa-300x209.jpg 300w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/2stt_hepa-1400x975.jpg 1400w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/2stt_hepa.jpg 1476w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">2.att\u0113ls. Hepasan\u00ae Forte nov\u0113rojuma AsAT izmai\u0146as asto\u0146u ned\u0113\u013cu period\u0101 pa vecumgrup\u0101m, v\/l<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Vid\u0113jais AlAT starp vecumgrup\u0101m pirms <em>Hepasan\u00ae Forte<\/em> lieto\u0161anas bija 66,85 v\/l (SN\u00b113,25) un p\u0113c asto\u0146\u0101m ned\u0113\u013c\u0101m bija 42,24 v\/l (SN\u00b13,29), kas liecina par r\u0101d\u012bt\u0101ju samazin\u0101\u0161anos par 24,61 v\/l (SN\u00b111,51)\u00a0 (sk. 3.att.).\u00a0<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"783\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/3stt_hepa-1024x783.jpg\" alt=\"\" class=\"wp-image-23157\" srcset=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/3stt_hepa-1024x783.jpg 1024w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/3stt_hepa-300x229.jpg 300w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/3stt_hepa-1400x1070.jpg 1400w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/3stt_hepa.jpg 1477w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">3.att\u0113ls. Hepasan\u00ae Forte nov\u0113rojuma AlAT izmai\u0146as asto\u0146u ned\u0113\u013cu period\u0101 pa vecumgrup\u0101m, v\/l<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Vis\u0101s vecumgrup\u0101s AsAT\/AlAT izmai\u0146as bija statistiski noz\u012bm\u012bgas, iz\u0146emot AlAT r\u0101d\u012bt\u0101jus jaun\u0101kai grupai \u2013 no 19 l\u012bdz 29 gadiem, kas var\u0113tu b\u016bt izskaidrojams ar nelielu respondentu skaitu grup\u0101.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Izv\u0113rt\u0113jot AsAT\/AlAT r\u0101d\u012bt\u0101jus atsevi\u0161\u0137i pa dzimumiem, vid\u0113j\u0101 AlAT\/AsAT l\u012bme\u0146a pazemin\u0101\u0161an\u0101s p\u0113c asto\u0146\u0101m ned\u0113\u013c\u0101m abiem dzimumiem bija statistiski noz\u012bm\u012bga (AlAT v\u012brie\u0161iem 39,01% (p=0,00002), sieviet\u0113m&nbsp; 40,16% (p&lt;0,00001); AsAT v\u012brie\u0161iem 33,27% (p=0,0001), sieviet\u0113m 32,91% (p=0,00006)).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vid\u0113jais kop\u0113j\u0101 bilirub\u012bna l\u012bmenis pirms <em>Hepasan\u00ae Forte<\/em> lieto\u0161anas bija 16,63 \u00b5mol\/l, un nov\u0113rot\u0101 pazemin\u0101\u0161an\u0101s par 3,28 \u00b5mol\/l jeb 19,72% nebija statistiski noz\u012bm\u012bga (p=0,936). Tie\u0161\u0101 bilirub\u012bna l\u012bme\u0146a pazemin\u0101\u0161an\u0101s 1,33 \u00b5mol\/l jeb 23,29% (p=0,832) l\u012bdz\u012bgi nebija statistiski noz\u012bm\u012bga (sk. 4.att.).<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"783\" src=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/4stt_hepa-1024x783.jpg\" alt=\"\" class=\"wp-image-23156\" srcset=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/4stt_hepa-1024x783.jpg 1024w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/4stt_hepa-300x229.jpg 300w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/4stt_hepa-1400x1071.jpg 1400w, https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/4stt_hepa.jpg 1476w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">4.att\u0113ls.  Hepasan\u00ae Forte nov\u0113rojuma kop\u0113j\u0101 bilirub\u012bna un tie\u0161\u0101 bilirub\u012bna r\u0101d\u012bt\u0101ju izmai\u0146as asto\u0146u ned\u0113\u013cu period\u0101, \u00b5mol\/l<\/figcaption><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\">Secin\u0101jumi<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Veiktais nov\u0113rojums pier\u0101da, ka, lietojot <em>Hepasan\u00ae Forte<\/em> asto\u0146as ned\u0113\u013cas pa div\u0101m kapsul\u0101m dien\u0101, statistiski noz\u012bm\u012bgi pazemin\u0101s AsAT un AlAT l\u012bmenis (vid\u0113jais AsAT par 17,23 v\/l jeb 33,07% (p&lt;0,00001) un vid\u0113jais AlAT par 27,60 v\/l jeb 39,66% (p&lt;0,00001)). Tika nov\u0113rota pozit\u012bva tendence kop\u0113j\u0101 bilirub\u012bna un tie\u0161\u0101 bilirub\u012bna r\u0101d\u012bt\u0101ju izmai\u0146\u0101s, tom\u0113r t\u0101 nebija statistiski noz\u012bm\u012bga.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tika nov\u0113rots, ka t\u0101di faktori k\u0101 dzimums un vecums neietekm\u0113 analiz\u0113to aknu r\u0101d\u012bt\u0101ju samazin\u0101\u0161anos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Visi pacienti augu prepar\u0101tu <em>Hepa\u00adsan\u00aeForte<\/em> panesa labi, blaknes netika konstat\u0113tas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>V\u0113res<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><em>Kalra, A., Yetiskul, E., Wehrle, C. J., &amp; Tuma, F. (2018). Physiology, liver.<\/em><\/li>\n\n\n\n<li><em>Madrigal-Santill\u00e1n, E., Madrigal-Bujaidar, E., \u00c1lvarez-Gonz\u00e1lez, I., Sumaya-Mart\u00ednez, M. T., Guti\u00e9rrez-Salinas, J., Bautista, M., Morales-Gonz\u00e1lez, J. A. (2014). Review of natural products with hepatoprotective effects.\u00a0World journal of gastroenterology: WJG,\u00a020(40), 14787.<\/em><\/li>\n\n\n\n<li><em>Zeisel SH. Choline. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, eds. Modern Nutrition in Health and Disease. 11th ed. Baltimore, MD: Lippincott Williams &amp; Wilkins; 2014:416\u201326.<\/em><\/li>\n\n\n\n<li><em>Hollenbeck, C. B. (2012). An introduction to the nutrition and metabolism of choline. Cent Nerv Syst Agents Med Chem 12 (2): 100\u2013113.<\/em><\/li>\n\n\n\n<li><em>U.S. Department of Agriculture, Agricultural Research Service.\u00a0FoodData Central, 2019<\/em><\/li>\n\n\n\n<li><em>Wiedeman, A. M., Barr, S. I., Green, T. J., Xu, Z., Innis, S. M., Kitts, D. D. (2018). Dietary choline intake: current state of knowledge across the life cycle.\u00a0Nutrients,\u00a010(10), 1513.<\/em><\/li>\n\n\n\n<li><em>Kansakar, U., Trimarco, V., Mone, P., Varzideh, F., Lombardi, A., Santulli, G. (2023). Choline supplements: An update.\u00a0Frontiers in Endocrinology,\u00a014, 1148166<\/em><\/li>\n\n\n\n<li><em>Wallace TC , Fulgoni VL3rd. Assessment of total choline intakes in the United States. J Am Coll Nutr2016;35:108\u201312.<\/em><\/li>\n\n\n\n<li><em>Mehedint, M. G., Zeisel, S. H. (2013). Choline\u2019s role in maintaining liver function: new evidence for epigenetic mechanisms.\u00a0Current opinion in clinical nutrition and metabolic care,\u00a016(3), 339.<\/em><\/li>\n\n\n\n<li><em>Dajani, A. I., Popovic, B. (2020). Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis.\u00a0World Journal of Clinical Cases,\u00a08(21), 5235.<\/em><\/li>\n\n\n\n<li><em>Gundermann, K. J., Gundermann, S., Drozdzik, M., Mohan Prasad, V. G. (2016). Essential phospholipids in fatty liver: a scientific update.\u00a0Clinical and experimental gastroenterology, 105\u2013117.<\/em><\/li>\n\n\n\n<li><em>Federico, A., Dallio, M., Loguercio, C. (2017). Silymarin\/silybin and chronic liver disease: a marriage of many years.\u00a0Molecules,\u00a022(2), 191.<\/em><\/li>\n\n\n\n<li><em>Gillessen, A., Schmidt, H. H. J. (2020). Silymarin as supportive treatment in liver diseases: A narrative review.\u00a0Advances in therapy,\u00a037(4), 1279\u20131301.<\/em><\/li>\n\n\n\n<li><em>Di Napoli, A., Zucchetti, P. (2021). A comprehensive review of the benefits of Taraxacum officinale on human health.\u00a0Bulletin of the National Research Centre,\u00a045(1), 1\u20137.<\/em><\/li>\n\n\n\n<li><em>Pfingstgraf, I. O., Taulescu, M., Pop, R. M., Or\u0103san, R., Vlase, L., Uifalean, A., P\u00e2rvu, A. E. (2021). Protective effects of Taraxacum officinale L.(Dandelion) root extract in experimental acute on chronic liver failure.\u00a0Antioxidants,\u00a010(4), 504.<\/em><\/li>\n\n\n\n<li><em>Amini, M. R., Sheikhhossein, F., Talebyan, A., Bazshahi, E., Djafari, F., Hekmatdoost, A. (2022). Effects of Artichoke Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.\u00a0Clinical Nutrition Research,\u00a011(3), 228.<\/em><\/li>\n\n\n\n<li><em>Moradi, S., Shokri\u2010Mashhadi, N., Saraf\u2010Bank, S., Mohammadi, H., Zobeiri, M., Clark, C. C., Rouhani, M. H. (2021). The effects of Cynara scolymus L. supplementation on liver enzymes: A systematic review and meta\u2010analysis.\u00a0International Journal of Clinical Practice,\u00a075(11), e14726.<\/em><\/li>\n\n\n\n<li><em>E. Gulbja laboratorija (2018). Kl\u012bnisko anal\u012b\u017eu rokasgr\u0101mata, 155\u2013158.<\/em><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"<p>Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. [&hellip;]<\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[5,76,191,214],"tags":[1540,3034],"mic_flag":[],"class_list":["post-23154","post","type-post","status-publish","format-standard","hentry","category-farmacija","category-jaunakie-raksti","category-reklamraksts","category-spec-vied","tag-aknas","tag-hepatoprotektori"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"ugis@mic.lv\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-10-22T11:08:54+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-22T11:20:01+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacija\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacija\\\/#listItem\",\"position\":2,\"name\":\"Farm\\u0101cija\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacija\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#listItem\",\"name\":\"Hepatoprotektori aknu slim\\u012bbu p\\u0101rvald\\u012bb\\u0101: aktu\\u0101lais\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#listItem\",\"position\":3,\"name\":\"Hepatoprotektori aknu slim\\u012bbu p\\u0101rvald\\u012bb\\u0101: aktu\\u0101lais\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacija\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#newsarticle\",\"name\":\"Hepatoprotektori aknu slim\\u012bbu p\\u0101rvald\\u012bb\\u0101: aktu\\u0101lais - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Hepatoprotektori aknu slim\\u012bbu p\\u0101rvald\\u012bb\\u0101: aktu\\u0101lais\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/1stt_hepa.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#articleImage\",\"width\":1476,\"height\":1041,\"caption\":\"1.att\\u0113ls. Hepasan\\u00ae Forte nov\\u0113rojuma AsAT\\\/AlAT r\\u0101d\\u012bt\\u0101ju izmai\\u0146as asto\\u0146u ned\\u0113\\u013cu period\\u0101, v\\\/l\"},\"datePublished\":\"2026-10-22T14:08:54+03:00\",\"dateModified\":\"2026-10-22T14:20:01+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Rekl\\u0101mraksts, Speci\\u0101lista viedoklis, aknas, Hepatoprotektori\",\"dateline\":\"Published on October 22, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/\",\"name\":\"ugis@mic.lv\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4454d24e3c5508a0c61b16269164ff61a96d6a9ea91d5a7a71b99ad72b41784a?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"ugis@mic.lv\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/\",\"name\":\"Hepatoprotektori aknu slim\\u012bbu p\\u0101rvald\\u012bb\\u0101: aktu\\u0101lais - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Kaspars Ivanovs, \\u0101rsts Jekaterina Parovin\\u010daka, Dr.pharm. Aknas ir viens no svar\\u012bg\\u0101kiem org\\u0101niem, kam ir b\\u016btiska loma da\\u017e\\u0101du procesu regul\\u0113\\u0161an\\u0101. Mijiedarbojoties ar endokr\\u012bno un gastrointestin\\u0101lo sist\\u0113mu, t\\u0101s atbalsta gremo\\u0161anu un vielmai\\u0146u. Akn\\u0101s glab\\u0101jas taukos \\u0161\\u0137\\u012bsto\\u0161ie vitam\\u012bni, dzelzs un var\\u0161, akn\\u0101m ir noz\\u012bme hematolo\\u0123ij\\u0101 \\u2013 asinsreces faktoru un olbaltumvielu sint\\u0113z\\u0113, holester\\u012bna homeost\\u0101zes nodro\\u0161in\\u0101\\u0161an\\u0101 un detoksik\\u0101cij\\u0101. Pasaul\\u0113 pacientu\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/ugis\\\/#author\"},\"datePublished\":\"2026-10-22T14:08:54+03:00\",\"dateModified\":\"2026-10-22T14:20:01+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs","description":"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu","canonical_url":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacija\/#listItem","name":"Farm\u0101cija"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacija\/#listItem","position":2,"name":"Farm\u0101cija","item":"https:\/\/farmacija-mic.lv\/category\/farmacija\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#listItem","name":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#listItem","position":3,"name":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacija\/#listItem","name":"Farm\u0101cija"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#newsarticle","name":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs","headline":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2026\/10\/1stt_hepa.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#articleImage","width":1476,"height":1041,"caption":"1.att\u0113ls. Hepasan\u00ae Forte nov\u0113rojuma AsAT\/AlAT r\u0101d\u012bt\u0101ju izmai\u0146as asto\u0146u ned\u0113\u013cu period\u0101, v\/l"},"datePublished":"2026-10-22T14:08:54+03:00","dateModified":"2026-10-22T14:20:01+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Rekl\u0101mraksts, Speci\u0101lista viedoklis, aknas, Hepatoprotektori","dateline":"Published on October 22, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/","name":"ugis@mic.lv","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4454d24e3c5508a0c61b16269164ff61a96d6a9ea91d5a7a71b99ad72b41784a?s=96&d=mm&r=g","width":96,"height":96,"caption":"ugis@mic.lv"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/","name":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs","description":"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/ugis\/#author"},"datePublished":"2026-10-22T14:08:54+03:00","dateModified":"2026-10-22T14:20:01+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs","og:description":"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu","og:url":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/","article:published_time":"2026-10-22T11:08:54+00:00","article:modified_time":"2026-10-22T11:20:01+00:00","twitter:card":"summary_large_image","twitter:title":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Kaspars Ivanovs, \u0101rsts Jekaterina Parovin\u010daka, Dr.pharm. Aknas ir viens no svar\u012bg\u0101kiem org\u0101niem, kam ir b\u016btiska loma da\u017e\u0101du procesu regul\u0113\u0161an\u0101. Mijiedarbojoties ar endokr\u012bno un gastrointestin\u0101lo sist\u0113mu, t\u0101s atbalsta gremo\u0161anu un vielmai\u0146u. Akn\u0101s glab\u0101jas taukos \u0161\u0137\u012bsto\u0161ie vitam\u012bni, dzelzs un var\u0161, akn\u0101m ir noz\u012bme hematolo\u0123ij\u0101 \u2013 asinsreces faktoru un olbaltumvielu sint\u0113z\u0113, holester\u012bna homeost\u0101zes nodro\u0161in\u0101\u0161an\u0101 un detoksik\u0101cij\u0101. Pasaul\u0113 pacientu"},"aioseo_meta_data":{"post_id":"23154","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"NewsArticle","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-22 11:08:57","updated":"2026-10-22 12:02:55"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/farmacija\/\" title=\"Farm\u0101cija\">Farm\u0101cija<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tHepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Farm\u0101cija","link":"https:\/\/farmacija-mic.lv\/category\/farmacija\/"},{"label":"Hepatoprotektori aknu slim\u012bbu p\u0101rvald\u012bb\u0101: aktu\u0101lais","link":"https:\/\/farmacija-mic.lv\/en\/hepatoprotektori-aknu-slimibu-parvaldiba-aktualais\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=23154"}],"version-history":[{"count":2,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23154\/revisions"}],"predecessor-version":[{"id":23161,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/23154\/revisions\/23161"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=23154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=23154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=23154"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=23154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}